ANL - adlainortye.com Long-Term Debt

Brandmark of Adlai Nortye Ltd (ANL)

The market value dynamics of the asset on GURU.Markets, which stands at 0.01, confirm the stability of the Adlai Nortye Ltd. (ANL) R&D center through high-quality venture capital and the recruitment of compliance experts. Adlai Nortye Ltd. (ANL) attracts biotechnologists by developing cutting-edge pharmaceuticals and implementing strict KPIs and incentive systems. Additionally, the company is expanding a global network of partnerships with medical centers to test targeted therapies against resistant tumors.

ANL - Adlai Nortye Ltd. Company Long-Term Liabilities over the range 02/21/2024 - 11/01/2026

Adlai Nortye - analytical breakdowns and key metrics (ANL)

- current quotes and average value forecast:
Stock Quotes Adlai Nortye Ltd|ANL - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Adlai Nortye|ANL - Total Company Value
- book capitalization data:
Accounting Value of a Share Adlai Nortye|ANL - Company Net Assets|Market Value to Book Value adlainortye.com|ANL - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio Adlai Nortye Ltd.|ANL - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Adlai Nortye Ltd|ANL - Company Debts|Debt to Net Assets Ratio Adlai Nortye|ANL - Company Long-Term Debts|Short-Term Debt Adlai Nortye|Quick Ratio adlainortye.com
- earnings and market ratios statistics:
ANL - Net Profit
Analysis of all company metrics:Adlai Nortye Ltd.
Mass-produced product of Adlai Nortye

Professional capital evaluates the profile of Adlai Nortye Ltd. (ANL) through the lens of long-term solvency and capital structure. By analyzing the organization's long-term financial debt, investors see a total of obligations with maturities exceeding one year, which, combined with stable demand for biotechnology, confirms the company's status as a defensive asset resilient to global macroeconomic shocks.

Who Adlai Nortye Ltd. competes with

ONC - Company Long-Term Liabilities|Halozyme - Company Long-Term Debts|Long-Term Debt Revolution Medicines Inc|Ascentage (AAPG) - Company Long-Term Debt|CG Oncology Therapeutics - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities URGN|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Debts PSNL|Company Long-Term Liabilities Erasca Inc ERAS|Delcath - Company Long-Term Liabilities|Company Long-Term Debts Y-mAbs Corp YMAB|AURA - Company Long-Term Debt|Company Long-Term Loans and Borrowings CADL (Candel Therapeutics)|ARAY: Company Long-Term Debts|Long-Term Debt SELLAS Life Sciences Group (SLS)|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Company Long-Term Debts Citius Oncology Inc|Company Long-Term Debts HURA|protaratx.com - Company Long-Term Indebtedness|Company Long-Term Debt Fate Therapeutics FATE|Aadi Bioscience, Inc. - Company Long-Term Debt|TScan - Company Long-Term Debts|CSBR - Company Long-Term Debts|XBIT: Company Long-Term Debts|CVM - Long-Term Debt Volume|Company Long-Term Liabilities OSTX|RADX: Company Long-Term Loans and Borrowings|Company Long-Term Debt Artiva Biotherapeutics, Inc. (ARTV)|Veru Corporation - Company Long-Term Indebtedness|Company Long-Term Debt Tempest Therapeutics TPST|Xilio Therapeutics Inc (XLO) - Long-Term Debt|RENB - Company Long-Term Debt|Company Long-Term Loans and Borrowings MURA (Mural Oncology plc)|KAPA (kairospharma.com) - Company Long-Term Liabilities|OKUR: Amount of Long-Term Liabilities|Company Long-Term Liabilities GDTC|Long-Term Debt Curis Corp CRIS|Company Long-Term Debts APLM|THAR - Long-Term Debt|Advanced Biomed - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings GNPX|CLDI - Company Long-Term Debt|SBFM: Company Long-Term Debt|XBIO (xeneticbio.com) - Company Long-Term Liabilities|SLRX: Amount of Long-Term Liabilities|PPBT (Purple Biotech Corp) - Company Long-Term Debts|Company Long-Term Indebtedness AONC (AON)|Company Long-Term Liabilities BGNE (BeiGene, Ltd.)|Long-Term Debt Volume checkpointtx.com|Company Long-Term Debts ELEV (Elevation Oncology, Inc.)|Company Long-Term Debts iCAD Inc. ICAD|IKNA - Company Long-Term Debt|NTBL (Notable Labs Corp) - Company Long-Term Indebtedness|viracta.com (VIRX) - Company Long-Term Debt|MOR (morphosys.com) - Company Long-Term Debt|NAYA (NAYA Biosciences Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Ascentage Pharma Group International (AAPGV)